Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation-Reference-Cited by-同舟云学术

Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation

Published:2019-11-26 Issue:24 Volume:62 Page:11151-11164
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yang Wei¹,Li Yingjun¹,Ai Yong¹,Obianom Obinna N.¹,Guo Dong¹,Yang Hong¹,Sakamuru Srilatha²,Xia Menghang²^ORCID,Shu Yan¹³^ORCID,Xue Fengtian¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States

2. National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bethesda, Maryland 20892, United States

3. School and Hospital of Stomatology, Guangzhou Medical University, Guangzhou 510140, China

Funder

National Center for Advancing Translational Sciences

National Natural Science Foundation of China

Maryland Innovation Initiative

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01252

Reference50 articles.